Autopsy report · NCT03898388

Correlating the OA Knee Microenvironment to Outcomes After Regenexx-SD Treatment: A Multi-Site Study

“sponsor discontinued study-impacted by COVID”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 years before it stopped.
• 47 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Regenexx, LLC

Sponsor type

Industry

Conditions

Knee Osteoarthritis

Interventions

Bone Marrow Concentrate treatment

Participants

47

Sites

3

Countries

United States

Trials that died the same way

• Randomized Controlled Study Comparing Colon Evaluation With The Pure-Vu System To A Standard Colonoscopy In Patients Who Are High Risk For Inadequate Bowel Preparation
  “Sponsor has terminated study due to COVID-19 related concerns” (85% match in meaning)
• Liking Adaptation to Beverages of Varying Sweetness Levels After Prolonged Exposure
  “Sponsor decision to stop study due to COVID-19 pandemic” (81% match in meaning)
• KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
  “Study discontinued due to sponsor decision.” (80% match in meaning)
• Duet TRS Used in Pulmonary Resections
  “Sponsor is no longer pursuing this study” (80% match in meaning)
• Parkinson's Disease G2019S LRRK2 Genetic Testing Program
  “Sponsor stopped the study” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.